CD86 and breast cancer: BC-BM pair ratios of CD86+ M1 to CD163+ M2 macrophages and CD86+ M1 to CD206+ M2 macrophages tended to be higher in primary BC than in BCBM with the triple-negative subtype (p = 0.13 and p = 0.082, respectively) (Figure S4e).